Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Cytokinetics, Incorporated (CYTK) had Debt to Capital Ratio of 1.27 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$18.47M |
|
$-589.53M |
|
-- |
|
$18.47M |
|
$554.72M |
|
$-536.25M |
|
$-53.28M |
|
$-589.53M |
|
$-589.53M |
|
$-589.53M |
|
$-589.53M |
|
$-589.53M |
|
$-589.53M |
|
$-536.25M |
|
$-526.72M |
|
111.98M |
|
111.98M |
|
$-5.26 |
|
$-5.26 |
|
| Balance Sheet Financials | |
$1.11B |
|
$65.81M |
|
$293.73M |
|
$1.40B |
|
$179.67M |
|
$645.60M |
|
$1.36B |
|
$1.54B |
|
$-135.37M |
|
$-135.37M |
|
$-135.37M |
|
118.21M |
|
| Cash Flow Statement Financials | |
$-395.89M |
|
$-553.10M |
|
$930.61M |
|
$113.40M |
|
$95.23M |
|
$-18.17M |
|
$97.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.17 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
1.27 |
-4.85 |
|
100.00% |
|
-2902.72% |
|
-2902.72% |
|
-2851.13% |
|
-3191.11% |
|
-3191.11% |
|
$-399.80M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.11 |
|
328.96 |
|
435.49% |
|
435.49% |
|
-42.06% |
|
-115.54% |
|
$-1.15 |
|
$-3.57 |
|
$-3.54 |
|